Hikma Pharmaceuticals USA Inc. [Cherry Hill / United States of America]
Hikma Pharmaceuticals USA Inc. [Cherry Hill / United States of America] located in CHERRY HILL NEW JERSEY, United States of America under the [Hikma Pharmaceuticals] organization had its last known inspection on 12 Jun 2024. There are 32 known inspections on record.
Site Details
Industries:
Human Drugs,
Animal Health,
Medical Devices
Tags:
Human Drugs,
FDF Manufacturer,
Sterile,
Repackaging,
Analytical Testing,
API Manufacturer,
Label,
Packaging,
Manufacturer,
Relabeling,
Generics,
Combination Product,
Medical Device Manufacturer,
Contract Manufacture Organization,
Animal Health,
Medical Devices
Parent Organization:
Hikma Pharmaceuticals
Last Inspection Date:
12 Jun 2024
FEI:
2220525
Redica ID:
Investigators:
Yvesna C Blaise,
Marea K Harmon,
Joy Rkozlowski Klena,
Rosario D'costa,
Margaret M Sands,
David A Oluwo,
Russell J Glapion,
Tamil Arasu, PhD,
Christian F Gomez Lugo,
Azeezat M Lawal,
Yoriann M Cabrera Bartolomei,
Devon Jenkins,
Nancy M Espinal,
Rochelle L Cross,
Christina K Theodorou,
Lori M Newman,
Justine Tomasso,
Loretta Nemchik,
Daniel J Grabicki,
Barbara Jwilimczyk Macri,
Paul L Bellamy,
Karen E D'orazio,
Sean R Marcsisin,
Jonathan G Matrisciano,
Krystyna M Kitson
Hikma Pharmaceuticals USA Inc. [Cherry Hill / United States of America]'s Most Recent Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2024 | FDA 483 | Hikma Pharmaceuticals USA Inc. - Form 483, 2024-06-12 |
November, 2023 | FDA 483 | Hikma Pharmaceuticals USA Inc. - Form 483, 2023-11-22 |
September, 2019 | FDA 483 | Hikma Pharmaceuticals USA Inc. - Form 483, 2019-09-10 |
October, 2013 | FDA 483 | Hikma Pharmaceuticals USA Inc. - Form 483, 2013-10-22 |
October, 2013 | EIR | Hikma Pharmaceuticals USA Inc. - EIR, 2013-10-22 |
Experience Redica Systems’ NEW site dashboards and profiles
Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![Site Profile Icon](https://redica.com/document-store/images/site-profile.png)
Loading...
Site Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more